A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
provide a process to lock and suspend domain names 
used to facilitate the online sale of drugs illegally, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Domain Reform for 
4
Unlawful Drug Sellers Act’’ or the ‘‘DRUGS Act’’. 
5
17:24 Dec 30, 2021
H6352
2 
•HR 6352 IH
SEC. 2. DOMAIN NAMES USED TO FACILITATE THE ONLINE 
1
SALE OF DRUGS ILLEGALLY. 
2
(a) IN GENERAL.—Subchapter A of chapter V of the 
3
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351 
4
et seq.) is amended by adding at the end the following: 
5
‘‘SEC. 524B. DOMAIN NAMES USED TO FACILITATE THE ON-
6
LINE SALE OF DRUGS ILLEGALLY. 
7
‘‘(a) IN GENERAL.—A registry operator or registrar 
8
shall— 
9
‘‘(1) not later than 24 hours after receipt of a 
10
notification from a trusted notifier respecting a do-
11
main name used to facilitate the online sale of drugs 
12
illegally that is under the control of the registry op-
13
erator or registrar, lock the domain name; and 
14
‘‘(2) not later than 7 days after receipt of such 
15
notification, suspend the domain name. 
16
‘‘(b) NOTICE.—For purposes of subsection (a), a no-
17
tification shall include, at a minimum— 
18
‘‘(1) the domain name being reported; 
19
‘‘(2) the date the alleged violations described in 
20
subsection (e)(2) were observed; 
21
‘‘(3) a summary of the alleged violations; and 
22
‘‘(4) a statement that evidence of offering drugs 
23
illegally, such as a screenshot, has been retained, 
24
and is available to be shared with the registry oper-
25
ator or registrar. 
26
17:24 Dec 30, 2021
H6352
3 
•HR 6352 IH
‘‘(c) REGISTRANT APPEAL.— 
1
‘‘(1) IN GENERAL.—Any registrant whose do-
2
main name is locked and suspended pursuant to 
3
subsection (a) may appeal such action to the trusted 
4
notifier pursuant to paragraph (2). The domain 
5
name shall remain locked and suspended until a 
6
final determination of the merits of the appeal has 
7
been made. 
8
‘‘(2) APPEALS.— 
9
‘‘(A) IN GENERAL.—In bringing such an 
10
appeal, the registrant for the locked and sus-
11
pended domain name may do any of the fol-
12
lowing: 
13
‘‘(i) Contact the applicable registry 
14
operator or registrar to request informa-
15
tion regarding the business name, or per-
16
sonal name if the trusted notifier is not a 
17
business, and the email address, of the 
18
trusted notifier who submitted the notifica-
19
tion regarding the domain name. 
20
‘‘(ii) Dispute the notification by sub-
21
mitting the following to the applicable 
22
trusted notifier: 
23
‘‘(I) A copy of the registrant’s 
24
pharmacy licenses for all jurisdictions 
25
17:24 Dec 30, 2021
H6352
4 
•HR 6352 IH
where it offered to ship prescription 
1
medicines at the time of the notifica-
2
tion where such licensure is legally re-
3
quired in such jurisdiction, or a copy 
4
of registrant’s affiliated pharmacy’s li-
5
censes for all jurisdictions where the 
6
registrant offered to facilitate the 
7
shipment of prescription medicines at 
8
the time of the notification where 
9
such licensure is legally required in 
10
such jurisdiction. 
11
‘‘(II) The license information of 
12
the medical practitioner involved in 
13
issuing the prescription facilitated in 
14
part by the registrant’s domain name 
15
where practitioner licensure is legally 
16
required in such jurisdiction. 
17
‘‘(B) PROVISION OF INFORMATION.—With-
18
in 15 days after receiving a request under sub-
19
paragraph (A)(i), a registry operator or reg-
20
istrar shall provide the requested information. 
21
‘‘(C) 
INVESTIGATION.—The 
applicable 
22
trusted notifier shall— 
23
‘‘(i) conduct a reasonable investigation 
24
regarding the registrant and its domain 
25
17:24 Dec 30, 2021
H6352
5 
•HR 6352 IH
name to determine whether notification 
1
under subsection (a) was improper; and 
2
‘‘(ii) in conducting such investigation, 
3
consider the information provided by the 
4
registrant under subparagraph (A). 
5
‘‘(D) SUCCESSFUL APPEAL.—If the appeal 
6
is successful, the registry operator or registrar 
7
shall lift the suspension and unlock the domain 
8
name within 15 days. 
9
‘‘(d) RULE OF CONSTRUCTION.—Nothing in this sec-
10
tion prohibits a registry operator or registrar from locking 
11
and suspending a domain name used to facilitate the on-
12
line sale of drugs illegally before receipt of a notification 
13
under this section from a trusted notifier. 
14
‘‘(e) DEFINITIONS.—In this section: 
15
‘‘(1) DOMAIN NAME.—The term ‘domain name’ 
16
means a name that— 
17
‘‘(A) identifies a specific location on the 
18
internet that belongs to a particular person; 
19
and 
20
‘‘(B) consists of two or more textual seg-
21
ments separated by dots. 
22
‘‘(2) DOMAIN NAME USED TO FACILITATE THE 
23
ONLINE SALE OF DRUGS ILLEGALLY.—The term ‘do-
24
main name used to facilitate the online sale of drugs 
25
17:24 Dec 30, 2021
H6352
6 
•HR 6352 IH
illegally’ means a domain name that identifies a lo-
1
cation on the internet the primary or a significant 
2
purpose of which is to introduce or deliver for intro-
3
duction into interstate commerce a drug or con-
4
trolled substance in violation of this Act or the Con-
5
trolled Substances Act. 
6
‘‘(3) LOCK.—The term ‘lock’ means, with re-
7
spect to a domain name, for the registry operator or 
8
registrar to systematically prevent the domain name 
9
from being updated, transferred, or deleted during 
10
the balance of the registration of the domain name, 
11
which may be achieved using domain name registra-
12
tion protocols. 
13
‘‘(4) PRESCRIPTION
DRUG.—The term ‘pre-
14
scription drug’ means a drug subject to section 
15
503(b)(1). 
16
‘‘(5) REGISTRAR.—The term ‘registrar’ means 
17
an organization that— 
18
‘‘(A) manages the registration of domain 
19
names; and 
20
‘‘(B) during the registration process— 
21
‘‘(i) verifies that the requested domain 
22
name meets registry requirements; and 
23
‘‘(ii) submits the name to the appro-
24
priate registry operator. 
25
17:24 Dec 30, 2021
H6352
7 
•HR 6352 IH
‘‘(6) REGISTRY.—The term ‘registry’ means an 
1
authoritative master database of the domain names 
2
registered in a top-level domain. 
3
‘‘(7) REGISTRY OPERATOR.—The term ‘registry 
4
operator’ means an organization that maintains a 
5
registry, including by— 
6
‘‘(A) receiving requests from registrars to 
7
add, delete, or modify domain names; and 
8
‘‘(B) making the requested changes in the 
9
registry. 
10
‘‘(8) SUSPEND.—The term ‘suspend’ means, 
11
with respect to a domain name, for the registry op-
12
erator or registrar to systematically disable the 
13
functionality of the domain name through a hold or 
14
suspension during the balance of the registration of 
15
the domain name, which may be achieved using do-
16
main name registration protocols. 
17
‘‘(9) TRUSTED NOTIFIER.—The term ‘trusted 
18
notifier’ includes the following (and the designees 
19
and agents thereof): 
20
‘‘(A) The Food and Drug Administration. 
21
‘‘(B) The Department of Justice, including 
22
the Drug Enforcement Administration. 
23
‘‘(C) The Department of Homeland Secu-
24
rity. 
25
17:24 Dec 30, 2021
H6352
8 
•HR 6352 IH
‘‘(D) A State attorney general. 
1
‘‘(E) A State board of pharmacy. 
2
‘‘(F) A nonprofit organization with a mem-
3
bership or governance comprised exclusively of 
4
representatives of— 
5
‘‘(i) agencies or officials specified in 
6
any of subparagraphs (A) through (E); or 
7
‘‘(ii) similarly positioned (as deter-
8
mined by the Commissioner of Food and 
9
Drugs) agencies or officials. 
10
‘‘(G) Any entity currently under contract 
11
or in a public-private partnership with the Food 
12
and Drug Administration or the Drug Enforce-
13
ment Agency to share information related to 
14
online drug sales. 
15
‘‘(H) Any other entity identified by the 
16
Food and Drug Administration as a trusted no-
17
tifier for purposes of this section, taking into 
18
consideration, at minimum, whether the enti-
19
ty— 
20
‘‘(i) is registered to do business in the 
21
United States; 
22
‘‘(ii) agrees to share notification data, 
23
upon request, with the Food and Drug Ad-
24
17:24 Dec 30, 2021
H6352
9 
•HR 6352 IH
ministration and the Drug Enforcement 
1
Agency; 
2
‘‘(iii) does not knowingly or with will-
3
ful ignorance approve or do business with 
4
entities that fail to adhere to the regula-
5
tions of the Food and Drug Administration 
6
or the Drug Enforcement Agency; and 
7
‘‘(iv) has published on the website of 
8
such entity policies and procedures for how 
9
the entity will issue notifications under 
10
subsection (a).’’. 
11
(b) PROHIBITED ACT.—Section 301 of the Federal 
12
Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amend-
13
ed by adding at the end the following: 
14
‘‘(fff) The failure by a registry operator or registrar 
15
to lock and suspend any domain name in its control in 
16
violation of section 524B.’’. 
17
(c) APPLICABILITY.—Sections 301(fff) and 524B of 
18
the Federal Food, Drug, and Cosmetic Act, as added by 
19
this section, shall apply beginning on the date that is 60 
20
days after the date of enactment of this Act. 
21
Æ 
17:24 Dec 30, 2021
H6352
